Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis

Acta Neurochir (Wien). 1999;141(5):481-6. doi: 10.1007/s007010050328.

Abstract

To identify features of meningiomas that infiltrate dura mater, and to examine the role Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion in meningiomas, a cell immunoblot assay study was performed in 20 meningiomas. MMP-9 secretion was detected in 20 (100%) meningiomas and was independent of histological features. TIMP-1 secretion was detected in 8 (40%) meningiomas. For a cell immunoblot volume which included approximately 1350 cells, there were 50.4 +/- 49.4 dots which showed immunoreactivity to MMP-9 and 2.0 +/- 4.2 which showed immunoreactivity to TIMP-1. The number of dots that showed immunoreactivity to MMP-9 was not significantly different between tumours with atypical and benign histological features. TIMP-1 secretion was found in only 8 (40%) specimens and the percentage of TIMP-1 secreting cells was significantly lower than that of MMP-9 secretion. Thus, we propose that meningiomas classified histologically as both atypical and benign have the potential to infiltrate dura mater.

MeSH terms

  • Adult
  • Aged
  • Collagenases / analysis*
  • Collagenases / metabolism
  • Female
  • Humans
  • Immunoblotting / methods
  • Immunohistochemistry
  • Male
  • Matrix Metalloproteinase 9
  • Meningeal Neoplasms / classification
  • Meningeal Neoplasms / metabolism*
  • Meningeal Neoplasms / pathology
  • Meningioma / classification
  • Meningioma / metabolism*
  • Meningioma / pathology
  • Metalloendopeptidases / metabolism*
  • Middle Aged
  • Tissue Inhibitor of Metalloproteinase-1 / analysis*
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism

Substances

  • Tissue Inhibitor of Metalloproteinase-1
  • Collagenases
  • Metalloendopeptidases
  • Matrix Metalloproteinase 9